Recombinant adeno-associated virus (rAAV) is a leading viral vector modality for gene therapy, with several approved treatments and hundreds of ongoing clinical trials. rAAV manufacturing, while ...

Dr. George is a physician-scientist whose clinical expertise is in disorders of hemostasis and thrombosis with a particular interest in hemophilia and hemophilia gene therapy. Her basic science ...

Tel Aviv University’s (TAU) new Translational Medical Research Center has acquired a VECTor PET/SPECT/CT to help bridge the gap between academic discoveries and new products that benefit patients. The ...

This proposal aims to develop an integrated, scalable, high-throughput recombinant adeno-associated virus (rAAV) screening and optimization platform to address the challenges associated with vector ...